biotech / news / / Euronews
Elecsys pTau217 is the first blood test designed to signal and rule out Alzheimer's disease.
Elecsys pTau217 is the first blood test cleared in Europe to rule out Alzheimer's disease.
KEY POINTS
- The test received CE Mark approval, allowing its use throughout the European Union.
- Elecsys pTau217 detects high pTau217 protein levels, indicating likely presence of amyloid plaques.
- A negative result can spare patients from invasive tests like spinal fluid analysis or brain scans.
- The test enables earlier Alzheimer's diagnosis in both primary and secondary care settings.
COMPANIES
Summarized by Newsio from Euronews. How we summarize →